Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Frontage Laboratories announces two senior appointments to lead its clinical services efforts. George Laskaris has been named Senior Director, Frontage Biometrics Services, bringing more than 20 years of programming, statistical and data management ...
read more
Thursday, February 12, 2015
The purpose of the new agreement is to ensure both organizations a future stronger position within the market for industrial consultancy.
read more
Wednesday, April 15, 2020
Cytel has launched an open-access global COVID-19 Clinical Trial Tracker to help facilitate greater collaboration.
read more
Specialist in early genotoxicity screening and mechanistic follow-up, Gentronix, is pleased to announce the findings of new research published by GlaxoSmithKline (GSK) on the miniaturisation and automation of BlueScreen™ HC; a proprietary assay ...
read more
Thursday, August 22, 2013
A workshop to discuss ways of improving the quality of drugs entering into the preclinical stage of development will be led by Ciriaco Maraschiello, PhD, director of drug discovery and translational medicines for Harlan Contract Research Services (...
read more
Thursday, August 08, 2013
Harlan Contract Research Services (CRS) Cytotest Cell Research GmbH in Rossdorf, Germany, has been named one of the first laboratories selected for inclusion in the European Union Network of Laboratories for the Validation of Alternative Methods (EU-...
read more
Harlan Contract Research Services and Bertin Pharma, headquartered in Montigny-le-Bretonneux, 3.France, announced a strategic partnership to offer a comprehensive package for early drug development. Under the agreement, the companies will offer a ...
read more
Wednesday, November 12, 2014
announces that Biocon, one of Asia’s premier biotechnology companies, has just launched INSUPen® EZ in India. The INSUPen® EZ is a second generation pen and follows on the success of Biocon’s premier insulin delivery device INSUPen®. Under the terms ...
read more
Friday, December 13, 2013
Okochi will have full profit and loss responsibility as well as overall accountability for all aspects of the Harlan Contract Research Services (CRS) business stream serving the Japanese chemical, agrochemical and pharmaceutical markets.
read more
Monday, November 17, 2014
Horizon Discovery Group plc (LSE: HZD) (Horizon), a leading provider of research tools to support translational genomics, , has today announced the formation of a new Scientific Advisory Board (SAB) for its Diagnostics Business Unit (Horizon ...
read more
Thursday, August 15, 2013
Nuevolution A/S today announced that it has entered into a scientific collaboration with Duke University, the Howard Hughes Medical Institute, and Lexicon Pharmaceuticals, Inc. for the investigation of the biological mechanism of action of a ...
read more
Tuesday, February 28, 2012
ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the acquisition of PriceSpective LLC, a global leader in value strategy consulting. The acquisition ...
read more
Tuesday, January 28, 2014
a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the appointment of Dr. Dariush Elahi as Director of Metabolic Research. Based in ICON’s Clinical Pharmacology ...
read more
ICON plc has made the following appointments:
Dr. Susan Anton, Director, Epidemiology and Risk Management Practice, ICON Late Phase & Outcomes Research
Dr. Susan Anton comes to ICON with over 25 years of experience leading international ...
read more
ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced details of its participation at the International Society for Pharmacoeconomics and Outcomes Research (...
read more